Keyword Search
PRESS RELEASE
May 21, 2026
Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting
PRESS RELEASE
May 19, 2026
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
PRESS RELEASE
May 07, 2026
Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update
PRESS RELEASE
Apr 23, 2026
Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time
PRESS RELEASE
Mar 17, 2026
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
PRESS RELEASE
Mar 06, 2026
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
PRESS RELEASE
Mar 02, 2026
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
PRESS RELEASE
Feb 26, 2026